Open AccessBasal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
Author(s) -
Origin Trial Investigators,
Hertzel C. Gerstein,
Jackie Bosch,
Gilles R. Dagenais,
Rafael Dı́az,
Hye Jung Jung,
Aldo P. Maggioni,
Janice Pogue,
Jeffrey L. Probstfield,
Ambady Ramachandran,
Matthew C Riddle,
Lars Rydén,
Salim Yusuf
Publication year - 2012
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1203858
Subject(s) - medicine , basal (medicine) , basal insulin , plasma glucose , insulin , endocrinology , diabetes mellitus , cardiology , type 2 diabetes
The provision of sufficient basal insulin to normalize fasting plasma glucose levels may reduce cardiovascular events, but such a possibility has not been formally tested.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom